Is Age Really a Non-Modifiable Cardiovascular Risk Factor?

American Journal of Cardiology

Volumn 104, Issue 9, 2009, Pages 1307-1310

  Kannel, William B ^a   Vasan, Ramachandran S ^a  

^a FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE;

AGING; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL EVALUATION; CLINICAL STUDY; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; EDUCATION; ELECTROCARDIOGRAPHY; GLUCOSE INTOLERANCE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; INCIDENCE; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULSE PRESSURE; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE;

AGING; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 72049118469     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.051     Document Type: Editorial

References (9)

1. Sniderman A.D., and Furberg C.D. Age as a modifiable risk factor for cardiovascular disease. Lancet 371 (2008) 1547-1549
2. Seshadri S., Beiser A., Kelly-Hayes M., Kase C.S., Au R., Kannel W.B., and Wolf P.A. The lifetime risk of stroke. Estimates from the Framingham study. Stroke 37 (2006) 345-350
3. Lloyd-Jones D., Larson M., and Beiser A. Lifetime risk of developing coronary heart disease. Lancet 353 (1999) 89-92
4. Lloyd-Jones D.M., Leip E.P., Larson M.G., D'Agostino R.B., Beiser A., Wilson P.W.F., Wolf P.A., and Levy D. Prediction of Lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113 (2006) 791-798
5. Terry D.F., Pencina M.J., Vasan R.S., Murabito J.M., Wolf P.A., Hayes M.K., Levy D., D'Agostino R.B., and Benjamin E.J. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc 53 (2005) 1944-1950
6. Goldberg R.J., Larson M., and Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham study. Arch Intern Med 156 (1996) 505-509
7. Willcox B.J., He Q., Chen R., Yano K., Masaki K.H., Grove J.S., Donlon T.A., Willcox C., and Curb J.D. Midlife risk factors and healthy survival in men. JAMA 296 (2006) 2343-2350
8. Yashin A.I., Akushevich I.V., Arbeev K.G., Akushevich L., Ukraintseva S.V., and Kulminsk A. Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study. Age 28 (2006) 363-367
9. D'Agostino Sr. R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., and Kannel W.B. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117 (2008) 743-753